Dietary intake and physical activity in a Canadian population sample of male patients with HIV infection and metabolic abnormalities

Current HIV Research

Volumn 6, Issue 1, 2008, Pages 82-90

  Arendt, Bianca Maria ^a   Aghdassi, Elaleh ^a   Mohammed, Saira Saddia ^a   Fung, Lillia Yan ^a   Jalali, Pegah ^a   Salit, Irving Elliot ^a   Allard, Johane Pierette ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Diet; HIV; Metabolic abnormalities; Micronutrients; Nutrition; Physical activity

Indexed keywords

ALPHA TOCOPHEROL; ANTIRETROVIRUS AGENT; MAGNESIUM; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRACE ELEMENT;

ADULT; ANTHROPOMETRY; CALORIC INTAKE; CANADA; CHOLESTEROL INTAKE; CLINICAL FEATURE; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; DYSLIPIDEMIA; EXERCISE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIPID DIET; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC DISORDER; NUTRITIONAL STATUS; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PROTEIN INTAKE; REFERENCE VALUE; REVIEW; SODIUM INTAKE; URBAN AREA; ARTICLE; COHORT ANALYSIS; DIET; HEALTH CARE POLICY; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; NUTRITIONAL ASSESSMENT;

ADULT; CANADA; COHORT STUDIES; DIET; ENERGY INTAKE; HIV INFECTIONS; HUMANS; MALE; METABOLIC SYNDROME X; MICRONUTRIENTS; MIDDLE AGED; MOTOR ACTIVITY; NUTRITION ASSESSMENT; NUTRITION POLICY; OBESITY;

EID: 40449129163     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016208783571973     Document Type: Review

References (80)

1. Batterham MJ, Garsia R, Greenop PA. Dietary, intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral therapy 'Diet FRS Study'. AIDS 2000; 14: 1839-1843.
2. Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001; 32: 130-139.
3. Jacobson DL, Tang AM, Spiegelman D, et al. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey). J Acquir Immune Defic Syndr 2006; 43: 458-466.
4. Hadigan C, Jeste S, Anderson EJ, Tsay R, Cyr H, Grinspoon S. Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution. Clin Infect Dis 2001; 33: 710-717.
5. Gavrila A, Tsiodras S, Doweiko J, et al. Exercise and vitamin E intake are independently associated with metabolic abnormalities in human immunodeficiency virus-positive subjects: a cross-sectional study. Clin Infect Dis 2003; 36: 1593-1601.
6. Shah M, Tierney K, Adams-Huet B, et al. The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy. HIV Med 2005; 6: 291-298.
7. Hendricks KM, Willis K, Houser R, Jones CY. Obesity in HIV-infection: dietary correlates Am Coll Nutr 2006; 25: 321-331.
8. Amorosa V, Synnestvedt M, Gross R, et al. A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr 2005; 39,:557-561.
9. Salyer J, Lyon DE, Settle J, Elswick RK, Rackley D. Coronary heart disease risks and lifestyle behaviors in persons with HIV infection. J Assoc Nurses AIDS Care 2006; 17: 3-17.
10. Suttajit M. Advances in nutrition support for quality of life in HIV+/ AIDS. Asia Pac J Clin Nutr 2007; 16 Suppl: 318-322.
11. Coyne-Meyers K, Trombley LE. A relview of nutrition in human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Nutr Clin Pract 2004; 19: 340-355.
12. Drain PK, Kupka R, Mugusi F, Fawzi WW. Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. Am J Clin Nutr 2007; 85: 333-345.
13. Tang AM, Graham NM, Kirby AJ, McCall LD, Willett WC, Saah AJ. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 1993; 138: 937-951.
14. Williams SB, Bartsch G, Muurahainen N, Collins G, Raghavan SS, Wheeler D. Protein intake is positively associated with body cell mass in weight-stable HIV-infected men. J Nutr 2003; 133: 1143-1146.
15. Beisel WR. Single nutrients and immunity. Am J Clin Nutr 1982; 35: 417-468.
16. Harhige LS. Nutrition and immunity with emphasis on infection and autoimmune disease. Nutr Health 1996; 10: 285-312.
17. Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV-infection. Am J Clin Nutr 1998; 67: 143-147.
18. Hulgan T, Morrow J, D'Aquila RT, et al. Oxidant stress is increased during treatment of human immunodeficiency virus infection. Clin Infect Dis 2003; 37: 1711-1717.
19. Jaruga P. [Oxidation mechanisms and anti-oxidation in HIV infected patients - effect on disease progression]. Postepy Hig Med Dosw 1999; 53: 43-54.
20. Dobmeyer TS, Findhammer S, Dobmeyer JM, et al. Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med 1997; 22: 775-785.
21. Pande V, Ramos MJ. Nuclear factor kappa B: a potential target for anti-HIV chemotherapy. Curr Med Chem 2003; 10: 1603-1615.
22. Lopez O, Bonnefont-Rousselot D, Edeas M, Emerit J, Bricaire F. Could antioxidant supplementation reduce antiretroviral therapy-induced chronic stable hyperlactatemia? Biomed Pharmacother 2003; 57: 113-116.
23. Ben-Romano R, Rudich A, Etzion S, et al. Nelfinavir induces adipocyte insulin resistance through the induction of oxidative stress: differential protective effect of antioxidant agents. Antivir Ther 2006; 11: 1051-1060.
24. Ferraresi R, Troiano L, Roat E, et al. Protective effect of acetyl-L-camitine against oxidative stress induced by antiretroviral drugs. FEBS Lett 2006; 580: 6612-6616.
25. Mondal D, Pradhan L, Ali M, Agrawal KC. HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells: exacerbation by inflammatory cytokines and amelioration by antioxidants. Cardiovasc Toxicol 2004; 4: 287-302.
26. Opii WO, Sultana R, Abdul HM, Ansari MA, Nath A, Butterfield DA. Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)-2′,3′-dideoxycytidine (ddC): relevance to HIV-dementia. Exp Neurol 2007; 204: 29-38.
27. Woods MN, Spiegelman D, Knox TA, et al. Nutrient intake and body weight in a large HIV cohort that includes women and minorities. J Am Diet Assoc 2002; 102: 203-211.
28. Hendricks KM, Sansavero M, Houser RF, Tang AM, Wanke CA. Dietary supplement use and nutrient intake in HIV-infected persons. AIDS Read 2007; 17: 211-216, 223-217.
29. Jones CY, Wilson IB, Greenberg AS, et al. Insulin resistance in HIV-infected men and women in the nutrition for healthy living cohort. J Acquir Immune Defic Syndr 2005; 40: 202-211.
30. Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press 1997.
31. Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press 1998.
32. Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc Washington, DC: National Academy Press 2000.
33. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids Washington, DC: National Academy Press 2000.
34. Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, DC: National Academy Press 2004.
35. Institute of Medicine. Dietary Reference Intakes: Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids Washington, DC: National Academy Press 2005.
36. Public Health Agency of Canada, Canadian Society for Exercise Physiology. Canada's Physical Activity Guide to Healthy Active Living. 1998. Available from: http://www.phac-aspc.gc.ca/pauuap/paguide/, accessed on July 26, 2007.
37. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 Suppl 1: S5-20.
38. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
39. Hokanson JE, Austin MA. Plasma triglyceride-level is a risk factor for cardiovascular disease independent of high-density lipopratein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-219.
40. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994; 89: 1333-1445.
41. Burchfiel CM, Laws A, Benfante R, et al. Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation 1995; 92: 1430-1436.
42. World Health Organization-WHO. Obesity: preventing and managing the global epidemic. Report No.: 894. Geneva 2000.
43. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999; 353: 2093-2099.
44. Aghdassi E, Arendt B, Salit IE, Allard JP. Estimation of body fat mass using dual energy x-ray absorptiometry, bioelectric impedance analysis, and anthropometry in HIV-positive male subjects receiving highly active antirotroviral therapy. JPEN J Parenter Enteral Nutr 2007; 31: 135-141.
45. Mohammed SS, Aghdassi E, Salit IE, et al. HIV-Positive Patients With Nonalcoholic Fatty Liver Disease Have a Lower Body Mass Index and Are More Physically Active Than HIV-Negative Patients. J Acquir Immune Defic Syndr 2007; 45: 432-438.
46. Millen B, Morgan JL. The 2D Food Portion Visual. Framingham, MA: Nutrition Consulting Enterprises; 1996.
47. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with imparied glucose tolerance. The Da Quing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
48. Murphy SP, Guenther PM, Kretsch MJ. Using the Dietary Reference Intakes to assess intakes of groups: Pitfalls to avoid. J Am Diet Assoc 2006; 106: 1550-1553.
49. Barr SI, Murphy SP, Poos MI. Interpreting and using the dietary references intakes in dietary assessment of individuals and groups. J Am Diet Assoc 2002; 102: 780-788.
50. Krauss RM, Eckel RH, Howard B, et al. AHA Scientific Statement: AHA Dietary Guidelines: Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association. J Nutr 2001; 131: 132-146.
51. Canadian Fitness and Lifestyle Research Institute. Meeting guidelines. Bulletin No. 31. Ottawa, Ontario, Canada; 1998
52. Statistics Canada. Leisure-time physical activity, by sex, household population aged 12 and over, Canada, provinces, territories, health regions and peer groups, 2005. Canadian Community Health Survey (CCHS 2.1 and 3.1) CANSIM table 105-0400. 2006. Available from: http//www.statcan.ca/english/freepub/82-221-XIE/2006001/tables/t002b.pdf, accessed on July 26, 2007.
53. Food and Nutrition Board. Recommended Dietary Allowances. 10th edition. Washington, DC: National Academy press; 1989.
54. Black AE, Prentice AM, Goldberg GR, et al. Measurements of total energy expenditure provide insights into the validity of dietary measurements of energy intake. J Am Diet Assoc 1993; 93: 572-579.
55. Hill RJ, Davies PS. The validity of self-reported energy intake as determined using the doubly labelled water technique. Br J Nutr 2001; 85: 415-430.
56. Jaime PC, Florindo AA, Latorre Mdo R, Segurado AA. Central obesity prid dietary intake in HIV/AIDS patients. Rev Saude Publica 2006; 40: 634-640.
57. Price GM, Paul AA, Cole TJ, Wadsworth ME. Characteristics of the low-energy reporters in a longitudinal national dietary survey. Br J Nutr 1997; 77: 833-851.
58. Batterham MJ, Morgan-Jones J, Gneenop P, Garsia R, Gold J, Caterson I. Calculating energy requirements for men with HIV/AIDS in the era of highly active antiretroviral therapy. Eur J Clin Nutr 200; 57: 209-217.
59. Shevitz AH, Knox TA, Spiegelman D, Roubenoff R, Gorbach SL, Skolnik PR. Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy. Aids 1999; 13: 1351-1357.
60. Lagerros YT, Mucci LA, Bellocco R, Nyren O, Balter O, Balter KA. Validity and reliability of self-reported total energy expenditure using a novel instrument. Eur J Epidemiol 2006; 21: 227-236.
61. Liese AD, Roach AK, Sparks KC, Marquart L, D'Agostino RB, Mayer-Davis EJ. Whole grain intake and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr 2003; 78: 965-971.
62. Hendricks KM, Dong KR, Tang AM, et al. High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition. Am J Clin Nutr 2003; 78: 790-795.
63. Becker U, Deis A, Sorensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996; 23: 1025-1029.
64. Stanger O, Herrmann W, Pietrzik K, et al. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol 2004; 93: 439-453.
65. van Asbeck BS, Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ. Anti-HIV effect of iron chelators: different mechanisms involved. J Clin Virol 2001; 20: 141-147.
66. Davi G, Falco A, Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 2005; 7: 256-268.
67. Pennathur S, Heinecke JW. Mechanisms for oxidative stress in diabetic cardiovascular disease. Antioxid Redox Signal 2007; 9: 955-969.
68. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007; 458: 48-56.
69. Gordeuk VR, Delanghe JR, Langlois MR, Boelaert JR. Iron status and the outcome of HIV infection: an overview. J Clin Virol 2001; 20: 111-115.
70. Tang AM, Lanzillotti J, Hendricks K, et al. Micronutrients: current issues for HIV care providers. AIDS 2005; 19: 847-861.
71. Lai H, Lai S, Shor-Posner G, Ma F, Trapido E, Baum MK. Plasma zinc, copper, copper:zinc ratio, and survival in a cohort of HIV-1-infected homosexual men. J Acquir Immune Defic Syndr 2001; 27: 56-62.
72. Friis-Moller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17: 1179-1193.
73. Brar I, Shuter J, Thomas A, Daniels E, Absalon J. A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. J Acquir Immune Defic Syndr 2007; 45: 66-71.
74. Mondy K, Overton ET, Grubb J, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis 2007; 44: 726-734.
75. Goris AH, Westerterp-Plantenga MS, Westerterp KR. Undereating and underrecording of habitual food intake in obese men: selective underreporting of fat intake. Am J Clin Nutr 2000; 71: 130-134.
76. Johansson G, Wikman A, Ahren AM, Hallmans G, Johansson I. Underreporting of energy intake in repeated 24-hour recalls related to gender, age, weight status, day of interview, educational level, reported food intake, smoking habits and area of living. Public Health Nutr 2001; 4: 919-927.
77. Boulos D, Yan P, Schanzer D, Remis RS, Archibald CP. Estimates of HIV prevalence and incidence in Canada, 2005. Can Commun Dis Rep 2006; 32(15): 165-74.
78. Public Health Agency of Canada. HIV/AIDS Epi Updates, August 2006: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; 2006.
79. Public Health Agency of Canada. HIV and AIDS in Canada. Surveillance Report to June 30, 2006. Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; 2006.
80. Fields-Gardner C, Fergusson P. Position of the American Dietetic Association and Dietitians of Canada: nutrition intervention in the care of persons with human immunodeficiency virus infection. J Am Diet Assoc 2004; 104: 1425-1441.